Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mechanisms mediating cancer cachexia

D Toomey1, H P Redmond, D Bouchier-Hayes

  • 1Department of Surgical Research, Royal College of Surgeons, Dublin, Ireland.

Cancer
|December 15, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Winner Winner Turkey Dinner! An Empirical Approach to Measuring Palatability and Satisfaction with Emergency Department Turkey Sandwiches.

Global journal of emergency medicine·2022
Same author

Perioperative cell-free DNA trends predict recurrence of non-metastatic colorectal cancer significantly earlier than CEA trends over the first 2 years post-operatively in stage II and stage III colon cancer.

International journal of colorectal disease·2022
Same author

Primary hyperparathyroidism causing posterior reversible encephalopathy syndrome: a case report.

Annals of the Royal College of Surgeons of England·2021
Same author

Risk of colorectal cancer associated with BRCA1 and/or BRCA2 mutation carriers: systematic review and meta-analysis.

The British journal of surgery·2020
Same author

Association between thyroid nodule size and malignancy rate.

Annals of the Royal College of Surgeons of England·2019
Same author

Meta-analysis of the diagnostic accuracy of ultrasound-guided fine-needle aspiration and core needle biopsy in diagnosing axillary lymph node metastasis.

The British journal of surgery·2018
Same journal

Long-term outcomes of evolving treatment regimens in Ewing sarcoma survivors diagnosed 1970-1999: A report from the Childhood Cancer Survivor Study.

Cancer·2026
Same journal

Large-scale osteosarcoma sequencing reveals age-associated genomic architectures.

Cancer·2026
Same journal

EZH2 inhibitor tazemetostat voluntarily withdrawn from market.

Cancer·2026
Same journal

Nivolumab and chemotherapy combination approved for previously untreated Hodgkin lymphoma.

Cancer·2026
Same journal

Most older patients with advanced cancer prioritize QOL over extending survival: A secondary analysis of the GAP70+ trial found that among adults aged 70 and older with advanced, noncurable cancer, nearly three-quarters prioritized maintaining QOL.

Cancer·2026
Same journal

Real-world safety, prognostic, and design considerations in ketogenic diet trials for pancreatic cancer.

Cancer·2026
See all related articles

Cancer cachexia involves metabolic and hormonal changes leading to significant weight loss. Current treatments targeting these metabolic pathways have shown limited success, necessitating careful consideration of therapeutic strategies.

Area of Science:

  • Oncology
  • Metabolic Medicine
  • Physiology

Background:

  • Cancer cachexia is a complex syndrome characterized by metabolic, hormonal, and cytokine abnormalities.
  • It contributes significantly to cancer-related mortality, potentially up to 30% of deaths.

Purpose of the Study:

  • To review metabolic interference pathways implicated in cancer cachexia.
  • To evaluate current knowledge and therapeutic approaches for cancer cachexia.

Main Methods:

  • A comprehensive literature search was conducted.
  • The search focused on metabolic pathways involved in cancer cachexia.

Main Results:

  • Cancer cachexia is marked by elevated basal metabolic rate and increased energy expenditure.

Related Experiment Videos

  • Systemic catabolism of muscle and adipose tissue are key manifestations.

    • Conclusions:

    • Elucidation of cachexia-related metabolic abnormalities has been limited.
    • Therapeutic manipulation of these pathways has yielded little success to date.
    • Generalizations regarding treatment regimens should be approached with caution.